The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
BAL: Exogenous (oil red O-stainable) lipids in BAL macrophages
Publications
Case 327: Exogenous Lipoid Pneumonia.
Radiology 2024 Jul;312;e222280 — 2024 Jul — e222280
Exogenous lipoid pneumonia: an important cause of interstitial lung disease in infants.
Respirology case reports 2018 Oct;6;e00356 — 2018 Oct — e00356
Lipoid pneumonia: an overview.
Expert review of respiratory medicine 2010 Dec;4;799-807 — 2010 Dec — 799-807
Lipoid pneumonia presenting as non resolving community acquired pneumonia: a case report.
Cases journal 2009 Dec 16;2;9332 — 2009 Dec 16 — 9332
[Lipoid pneumonia - an underestimated syndrome].
Deutsche medizinische Wochenschrift (1946) 2010 Jan;135;27-31 — 2010 Jan — 27-31
Lung infiltrate in a male with a bronchopleural fistula.
The European respiratory journal 2003 Jun;21;1078-80 — 2003 Jun — 1078-80
Images in clinical medicine. Exogenous lipoid pneumonia.
The New England journal of medicine 1998 Feb 19;338;512 — 1998 Feb 19 — 512
Bronchoalveolar lavage in liquid paraffin pneumonitis.
Chest 1990 Nov;98;1149-55 — 1990 Nov — 1149-55